Crossmark

Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k/Akt/mTOR pathway

Crossref DOI link: https://doi.org/10.1007/s00432-024-05658-w

Published Online: 2024-03-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guo, Man

Liu, Mengyue

Li, Weihan

Wang, Cao

Zhang, Lu

Zhang, Hao
Funding

Funding for this research was provided by:

Key Scientific and Technological Project of Henan Province (202102310096)
License Information

Text and Data Mining valid from 2024-03-25

Version of Record valid from 2024-03-25
More Information

Article History

Received: 13 November 2023

Accepted: 20 February 2024

First Online: 25 March 2024

Declarations

:

: There is no conflict of interest.

: All animal experiment procedures were operated according to the NIH Guide for the Care and Use of Laboratory Animals approved by the ethical committee of Nanyang Central Hospital affiliated to Henan University (APPROVAL NUMBER: XYLL-20210132).

: All the authors agree to the study being published.

Document is current

Any future updates will be listed below